ICER estimates submitted to UK NICE suggestive of funding bias?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.469, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acceptable ICER for rufinamide in LGS?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 600, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

UK NICE Citizens Council a token gesture?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 378, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

UK NICE squares up to Australian PBAC, is the US ripe for NICE?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Neuropsychotherapeutics in the UK: What Has Been the Impact of NICE on Prescribing?

By Walley T.

CNS Drugs, Vol. 18, Iss. 1, 2004-01 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite

Could a patient-based formula guide funding allocation in the UK?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 643, 2011-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite